Both Croda’s US sites receive GMP certification for excipients

6-Apr-2017

The scope covers alkyloxylates, esters, super refined oils and polyethylene glycol (PEG)

Both Croda manufacturing sites in the USA have been awarded an EXCiPACT Certificate from SGS, one of EXCIPACT’s internationally-recognised Certification Bodies.

The certificates demonstrates that the Croda sites in Mill Hall, Pennsylvania and in New Castle, Delaware manufacture pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard.

Sign up for your free email newsletter

The scope covers the manufacturing of alkyloxylates, esters, super refined oils and polyethylene glycol (PEG) at Mill Hall, as well as alkyloxylates and esters at New Castle.

Companies